Eli Lilly and Novo Nordisk already produce popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data from the AVONELLE-X and SALWEEN ...

Biotechnology pioneer Genentech broke ground Monday on a $700 million manufacturing facility in Holly Springs, marking the ...

Genentech breaks ground on a new facility in Holly Springs, North Carolina, marking the state's growth in biotech.

Roche’s Genentech unit has handed over $20 million in upfront cash for the license to Omass Therapeutics’ preclinical inflammatory bowel disease (IBD) program. | Roche’s Genentech unit has handed over ...

The OMass partnership will boost Roche’s strategy in inflammatory bowel diseases, currently led by afimkibart, an anti-TL1A ...

Genentech, a member of the Roche Group, has commenced construction of a new manufacturing site in Holly Springs, North ...

The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D. The facility ...

OMass Therapeutics partners with Genentech to advance innovative treatments for inflammatory bowel disease, leveraging their ...

Genentech recently announced a series of marketing leadership hires to start off the new year. The biotech company hired Erica Taylor, PhD, as the company’s first chief marketing officer and tabbed ...

Genentech, a member of Roche (RHHBY), announced new data from the AVONELLE-X and SALWEEN studies of Vabysmo, presented at the 25th Euretina ...

The South San Francisco-based biotech company Genentech will pay penalties over 2021 hazardous waste violations, the Environmental Protection Agency announced Tuesday.